Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on May 28, 2025
Pulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
REDWOOD CITY, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced the company will be presenting at the Goldman Sachs …
Cytek Biosciences to participate at the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
FREMONT, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming Goldman Sachs 46th Annual Global Healthcare Conference in …
ORIC® Pharmaceuticals Announces $125 Million Private Placement Financing
GlobeNewswire
·
May 28, 2025
Financing led by SR One and includes participation from new and existing investors, including Point72, Viking Global Investors, Venrock Healthcare Capital Partners, New Enterprise Associates (NEA), Nextech, Vivo Capital, and NEXTBio Capital Pro forma cash …
ORIC® Pharmaceuticals Announces Potentially Best-In-Class Preliminary Efficacy and Safety Data from Ongoing Phase 1b Trial of ORIC-944 in Combination with AR Inhibitors for the Treatment of Patients with mCRPC
GlobeNewswire
·
May 28, 2025
Broad and deep PSA responses achieved, with 59% PSA50 response rate (confirmed rate of 47%, and one additional response pending confirmation) and 24% PSA90 response rate (all confirmed) in patients with mCRPC PSA responses were observed across all …
Sanuwave Health Appoints Greg Bazar to Board of Directors
GlobeNewswire
·
May 28, 2025
EDEN PRAIRIE, Minn., May 28, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (Nasdaq:SNWV), a leading provider of next-generation FDA-approved wound care products, is pleased to announce the addition of Greg Bazar to its Board …
Sana Biotechnology to Present at June 2025 Investor Conferences
GlobeNewswire
·
May 28, 2025
SEATTLE, May 28, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at two investor conferences in June. …
Artiva Biotherapeutics to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients with devastating autoimmune diseases and …
Adaptive Biotechnologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
SEATTLE, May 28, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, …
Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
GlobeNewswire
·
May 28, 2025
DALLAS, May 28, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the …
argenx Announces Results of Annual General Meeting of Shareholders
GlobeNewswire
·
May 28, 2025
May 28, 2025 – 10:01 PM CET Amsterdam, the Netherlands – argenx SE (Euronext …
Century Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 Congress
GlobeNewswire
·
May 28, 2025
PHILADELPHIA, May 28, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in autoimmune disease and cancer, today …
Corvus Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
SOUTH SAN FRANCISCO, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that members of its leadership team will conduct one-on-one meetings with investors and …
Taysha Gene Therapies Announces Pivotal Part B Trial Design Details for TSHA-102 in Rett Syndrome Enabled by IRSF Natural History Data and Positive Clinical Data from Part A of the REVEAL Adult/Adolescent and Pediatric Trials Evaluating TSHA-102
GlobeNewswire
·
May 28, 2025
Natural history data analysis established patients ≥ six years of age are in developmental plateau, with a ~0% likelihood of gaining/regaining developmental milestones across the core functional domains of Rett syndrome Written alignment from FDA supports …
Disc Medicine to Participate in Upcoming Investor Conferences
GlobeNewswire
·
May 28, 2025
WATERTOWN, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious …
EyePoint Announces Participation at Upcoming Investor Conferences
GlobeNewswire
·
May 28, 2025
WATERTOWN, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced …
Caribou Biosciences to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
BERKELEY, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced Rachel Haurwitz, PhD, Caribou’s president and chief executive officer, …
Aurora Spine Corporation to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
GlobeNewswire
·
May 28, 2025
CARLSBAD, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in spine and interventional spine technology that improves spinal surgery outcomes, today announced it will …
SPR Announces Publication of Sustained Chronic Shoulder Pain Outcomes Up to Five Years Post-Treatment
GlobeNewswire
·
May 28, 2025
CLEVELAND, May 28, 2025 (GLOBE NEWSWIRE) -- SPR announced the peer-reviewed publication of additional survey data demonstrating the impact of SPR® SPRINT® PNS treatment on chronic shoulder pain. Shoulder pain is one of the most common locations of chronic …
31 Million Seniors Lack Dental Coverage, According to NADP Foundation-Funded Paper
GlobeNewswire
·
May 28, 2025
DALLAS, May 28, 2025 (GLOBE NEWSWIRE) -- A new white paper from Charm Economics, a 2025 grant recipient of the National Association of Dental Plans (NADP) Foundation, reveals a critical gap in dental coverage among older Americans. The study estimates that …
EvergreenHealth Seeks First-Ever Levy Lid Lift to Expand Access to Care and Plan for Future Needs
GlobeNewswire
·
May 28, 2025
KIRKLAND, Wash., May 28, 2025 (GLOBE NEWSWIRE) -- This August, voters in King County Public Hospital District #2 will be asked to consider Proposition 1, EvergreenHealth’s first-ever Levy Lid Lift request since the hospital opened in 1972. If approved, the …